Can biosimilars lead us to prescription drug affordability?

Prescription drug costs are undoubtedly a hot topic in our nation right now; and rightfully so. As leaders of the pharmacy team for Blue Cross and Blue Shield of Kansas, we are constantly looking for ways to improve affordability of prescription drugs for our members. We put a lot of thought and research into what preferred products we should cover – taking our members’ best interests into consideration. One of the lights at the end of the tunnel may come in the form of biosimilar drugs. Biosimilar…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news